Neurology Archives | Report Store

show blocks helper

Sort by Default Order
- Default Order
- Name
- Price
- Date
- Popularity

Click to order products descending

Display 15 Products per page

Market Spotlight: Insomnia

$1,318.00

This Market Spotlight report covers the insomnia market, comprising key marketed and pipeline drugs, clinical trials, recent events and analyst opinion, key upcoming events and regulatory events, probability of success, patent information, a 10-year disease prevalence forecast, and licensing and acquisition deals, as well as presenting drug-specific revenue forecasts.
March 6, 2019
Find out more
Alzheimer’s Disease Market and Forecast Analysis 2034

$22,000.00

Alzheimer’s disease is an irreversible, progressive, neurodegenerative, and fatal disease that slowly affects memory, cognition, and function.
February 25, 2019
Find out more
Pediatric Epilepsy KOL Interview – US, West

$599.00

A US expert in pediatric epilepsy provides insight into the approach to treating different forms of epilepsy. The key opinion leader (KOL) dives into the late-phase pipeline for epilepsy, as well as sharing insight into Epidiolex.
February 18, 2019
Find out more
Epilepsy KOL Interview – US, West

$599.00

A US key opinion leader (KOL) discusses the epilepsy treatment landscape, including new market entrant Epidiolex, and provides their perspective on late-phase pipeline anti-epileptic drugs such as Fintepla.
February 18, 2019
Find out more
Market Spotlight: Attention Deficit Hyperactivity Disorder (ADHD)

$1,318.00

This Market Spotlight report covers the Attention Deficit Hyperactivity Disorder (ADHD) market, comprising key marketed and pipeline drugs, clinical trials, recent events and analyst opinion, upcoming and regulatory events, probability of success, patent information, a 10-year disease prevalence forecast, and licensing and acquisition deals, as well as presenting drug-specific revenue forecasts.
February 13, 2019
Find out more
Market Spotlight: Amyotrophic Lateral Sclerosis (ALS)

$1,318.00

This Market Spotlight report covers the Amyotrophic Lateral Sclerosis (ALS) market, comprising key pipeline and marketed drugs, clinical trials, upcoming and regulatory events, patent information, a 10-year disease prevalence forecast, and licensing and acquisition deals, as well as presenting drug-specific revenue forecasts.
January 30, 2019
Find out more
Market Spotlight: Fragile X Syndrome

$1,318.00

This Market Spotlight report covers the Fragile X Syndrome market, comprising key pipeline drugs, clinical trials, upcoming and regulatory events, patent information, a discussion on disease epidemiology, and licensing and acquisition deals.
January 28, 2019
Find out more
Alzheimer’s Disease KOL Interview – US, Northeast

$599.00

This interview with a US key opinion leader (KOL) provides insight into data from various late-phase Alzheimer’s disease pipeline therapies, as well as a discussion of the design of these trials. Also discussed are treatment trends and current unmet needs.
January 28, 2019
Find out more
Alzheimer’s Disease KOL Interview – US, South

$599.00

This interview with a US key opinion leader (KOL) provides insight into data from various late-phase Alzheimer’s disease pipeline therapies, as well as a discussion of the design of these trials. Also discussed are treatment trends and current unmet needs.
January 28, 2019
Find out more
Market Spotlight: Migraine

$1,318.00

This Market Spotlight report covers the migraine market, comprising key marketed and pipeline drugs, clinical trials, recent events and analyst opinion, upcoming and regulatory events, probability of success, patent information, a 10-year disease prevalence forecast, and licensing and acquisition deals, as well as presenting drug-specific revenue forecasts.
January 22, 2019
Find out more
Alzheimer’s Disease KOL Interview – UK

$599.00

This interview with a UK key opinion leader (KOL) provides an overview of cost-effectiveness criteria that may be required to bring Alzheimer’s disease products successfully to the clinic in the UK. We also discuss current and potential treatment options, as well as unmet needs in Alzheimer’s disease.
January 20, 2019
Find out more
Market Spotlight: Huntington’s Disease

$1,318.00

This Market Spotlight report covers the Huntington’s disease market, comprising key pipeline and marketed drugs, clinical trials, upcoming and regulatory events, patent information, a 10-year disease prevalence forecast, and licensing and acquisition deals, as well as presenting drug-specific revenue forecasts.
January 17, 2019
Find out more
Migraine Disease Coverage Forecast and Market Analysis

$22,000.00

Migraine is a common, disabling, and recurring neurological disorder characterized by severe headache co-occurring with nausea, vomiting, and other symptoms, the duration of which can range from hours to days.
January 8, 2019
Find out more
Market Spotlight: Systemic Hypertension

$1,318.00

This Market Spotlight report covers the Systemic Hypertension market, comprising key pipeline and marketed drugs, clinical trials, upcoming and regulatory events, patent information, a 10-year disease prevalence forecast, and licensing and acquisition deals, as well as presenting drug-specific revenue forecasts.
December 21, 2018
Find out more
Interventional Neurology: Carotid Artery Stents and Embolic Protection Systems

$4,750.00

This analysis includes a discussion of competitors, markets (current and future), products, and opportunities in the global market for carotid artery stents and embolic protection systems. Geographic areas covered by this analysis include the US, the five major EU markets, Japan, and the rest of the world. This report is part of a series of reports covering the interventional neurology market for stroke treatments.
December 18, 2018
Find out more

Neurology

Neurology

Market Spotlight: Insomnia

Alzheimer’s Disease Market and Forecast Analysis 2034

Pediatric Epilepsy KOL Interview – US, West

Epilepsy KOL Interview – US, West

Market Spotlight: Attention Deficit Hyperactivity Disorder (ADHD)​

Market Spotlight: Amyotrophic Lateral Sclerosis (ALS)

Market Spotlight: Fragile X Syndrome

Alzheimer’s Disease KOL Interview – US, Northeast

Alzheimer’s Disease KOL Interview – US, South

Market Spotlight: Migraine

Alzheimer’s Disease KOL Interview – UK

Market Spotlight: Huntington’s Disease

Migraine Disease Coverage Forecast and Market Analysis

Market Spotlight: Systemic Hypertension

Interventional Neurology: Carotid Artery Stents and Embolic Protection Systems

Market Spotlight: Attention Deficit Hyperactivity Disorder (ADHD)